Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000950103-25-005067
Filing Date
2025-04-18
Accepted
2025-04-18 17:06:44
Documents
1
Period of Report
2025-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 4 dp227912_4-tennant.html 4  
1 FORM 4 dp227912_4-tennant.xml 4 4025
  Complete submission text file 0000950103-25-005067.txt   5546
Mailing Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876 301-556-9900
PRECIGEN, INC. (Issuer) CIK: 0001356090 (see all company filings)

EIN.: 000000000 | State of Incorp.: VA | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PRECIGEN, INC. 20374 SENECA MEADOWS PARKWAY GERMANTOWN MD 20876
Business Address
Tennant Phil (Reporting) CIK: 0002030874 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36042 | Film No.: 25850852